Results of treatment of esophageal variceal hemorrhage with endoscopic injection of n-butyl-2-cyanoacrylate in patients with Child-Pugh class C cirrhosis

Background and study aims: The results of endoscopic treatment with elastic band ligation for esophageal variceal bleeding in patients with Child-Pugh class C cirrhosis remain poor. In comparison with treatment with elastic band ligation, we have found lower rates of rebleeding and mortality with n-butyl-2-cyanoacrylate injections. Thus, the aim of the current study was to describe our unit’s 10 years of experience with injection of n-butyl-2-cyanoacrylate to control esophageal variceal ruptures in patients with Child-Pugh class C cirrhosis.

Patients and methods: A single-center, retrospective study was conducted. Sixty-three patients with Child-Pugh class C cirrhosis had been admitted to the center with an acute episode of esophageal variceal bleeding. All were treated with injection of n-butyl-2-cyanoacrylate. The patients were assigned to 1 of 2 groups according to their Child-Pugh class C cirrhosis scores: group I (score range, 10 through 13 points) and group II (score, 14 or 15 points). The 3 variables studied were rates of initial failure to control bleeding, failure to prevent rebleeding (secondary prophylaxis), and mortality. Patients in the 2 groups (group I, n = 50; group II, n = 13) had similar characteristics.

Results: Bleeding was successfully controlled in almost 75 % of the patients during the first 5 days after treatment, with no significant differences observed between groups I and II. There were no significant differences between the 2 groups with respect to mortality rate for the first 5 days after treatment. Thirty-four patients (54 %) were free of bleeding at 6 weeks after treatment, with a significant difference noted between the groups: group I, 64 %, versus group II, 15.4 % (P < 0.001). The overall mortality rate was 44.4 %, with a significant difference noted between the groups: group I, 34 %, versus group II, 84.6 % (P < 0.001).

Conclusion: Endoscopic injection of n-butyl-2-cyanoacrylate is a valid treatment option to control esophageal variceal bleeding in patients with a Child-Pugh class C cirrhosis score in the range of 10 through 13 points.

• References

• 1 El Atti EA, Nevens F, Bogaerts K et al. Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension. Gut 1999; 45: 618-621
• 2 van Buuren HR, Rasch MC, Batenburg PL et al. Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices: a randomized controlled multicentre trial [ISRC TN03215899]. BMC Gastroenterol 2003; 3: 22
• 3 de Franchis R, Bañares R, Silvain C. Emergency endoscopy strategies for improved outcomes. Scand J Gastroenterol Suppl 1998; 226: 25-36
• 4 McCormick PA, O’Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49: 682-685
• 5 de Franchis R. Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768
• 6 García-Pagán JC, Caca K, Bureau C et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-2379
• 7 Bittencourt PL, Farias AQ, Strauss E et al. Variceal bleeding: consensus meeting report from the Brazilian Society of Hepatology. Arq Gastroenterol 2010; 47: 202-216
• 8 Luz GO, Maluf-Filho F, Matuguma SE et al. Comparison between endoscopic sclerotherapy and band ligation for hemostasis of acute variceal bleeding. World J Gastrointest Endosc 2011; 3: 95-100
• 9 North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988; 319: 983-989
• 10 Maluf-Filho F, Sakai P, Ishioka S et al. Endoscopic sclerosis versus cyanoacrylate endoscopic injection for the first episode of variceal bleeding: a prospective, controlled, and randomized study in Child-Pugh class C patients. Endoscopy 2001; 33: 421-427
• 11 Cipolletta L, Zambelli A, Bianco MA et al. Acrylate glue injection for acutely bleeding oesophageal varices: a prospective cohort study. Dig Liver Dis 2009; 41: 729-734
• 12 Ljubicić N, Bisćanin A, Nikolić M et al. A randomized-controlled trial of endoscopic treatment of acute esophageal variceal hemorrhage: N-butyl-2-cyanoacrylate injection vs. variceal ligation. Hepatogastroenterology 2011; 58: 438-443
• 13 Santos MM, Tolentino LH, Rodrigues RA et al. Endoscopic treatment of esophageal varices in advanced liver disease patients: band ligation versus cyanoacrylate injection. Eur J Gastroenterol Hepatol 2011; 23: 60-65
• 14 Evrard S, Dumonceau JM, Delhaye M et al. Endoscopic Histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy 2003; 35: 729-735
• 15 Kim EK, Sohn JH, Kim TY et al. [Esophageal sinus formation due to cyanoacrylate injection for esophageal variceal ligation-induced ulcer bleeding in a cirrhotic patient]. Korean J Gastroenterol 2011; 57: 180-183
• 16 Martins Santos MM, Correia LP, Rodrigues RA et al. Splenic artery embolization and infarction after cyanoacrylate injection for esophageal varices. Gastrointest Endosc 2007; 65: 1088-1090
• 17 Chen YY, Shen TC, Soon MS et al. Life-threatening pericarditis after N-butyl-2-cyanoacrylate injection for esophageal variceal bleeding: case report. Gastrointest Endosc 2005; 61: 487-489
• 18 Gallet B, Zemour G, Saudemont JP et al. Echocardiographic demonstration of intracardiac glue after endoscopic obturation of gastroesophageal varices. J Am Soc Echocardiogr 1995; 8: 759-761
• 19 Sarin SK, Kumar A. Gastric varices: profile, classification, and management. Am J Gastroenterol 1989; 84: 1244-1249